Table of Contents
168 relations: Adjuvant therapy, Adrenergic receptor, Adult attention deficit hyperactivity disorder, Agonist, Akathisia, Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-2A adrenergic receptor, Alpha-2B adrenergic receptor, Alpha-2C adrenergic receptor, Amphetamine, Amphetamine dependence, Anaphylaxis, Anorexia (symptom), Antipsychotic, Aripiprazole lauroxil, Asenapine, Attention deficit hyperactivity disorder, Atypical antipsychotic, Australia, Autism, Barr Pharmaceuticals, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Bioavailability, Bipolar disorder, Bloomberg L.P., Boxed warning, Breastfeeding, Bristol Myers Squibb, British National Formulary, Carbamazepine, Cariprazine, Case report, Caudate nucleus, Chemical synapse, Chlorpromazine, Citalopram, Clinical trial, Clozapine, Cochrane (organisation), Crystal polymorphism, CYP2D6, CYP3A4, Dementia, Depression (mood), Diário Oficial da União, Digital pill, Dopamine receptor D1, Dopamine receptor D2, ... Expand index (118 more) »
- 5-HT2B antagonists
- 5-HT2C agonists
- 5-HT7 antagonists
- Atypical antipsychotics
- D2 antagonists
- D2-receptor agonists
- D3 antagonists
- D3 receptor agonists
- Mood stabilizers
- Otsuka Pharmaceutical
- Serotonin-dopamine activity modulators
- Tetrahydroquinolines
- Treatment of autism
Adjuvant therapy
Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial therapy to maximize its effectiveness.
See Aripiprazole and Adjuvant therapy
Adrenergic receptor
The adrenergic receptors or adrenoceptors are a class of G protein-coupled receptors that are targets of many catecholamines like norepinephrine (noradrenaline) and epinephrine (adrenaline) produced by the body, but also many medications like beta blockers, beta-2 (β2) agonists and alpha-2 (α2) agonists, which are used to treat high blood pressure and asthma, for example.
See Aripiprazole and Adrenergic receptor
Adult attention deficit hyperactivity disorder
Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood.
See Aripiprazole and Adult attention deficit hyperactivity disorder
Agonist
An agonist is a chemical that activates a receptor to produce a biological response.
Akathisia
Akathisia (IPA: /æ.kə.ˈθɪ.si.ə/) is a movement disorder characterized by a subjective feeling of inner restlessness accompanied by mental distress and an inability to sit still.
See Aripiprazole and Akathisia
Alpha-1A adrenergic receptor
The alpha-1A adrenergic receptor (α1A adrenoreceptor), also known as ADRA1A, formerly known also as the alpha-1C adrenergic receptor, is an alpha-1 adrenergic receptor, and also denotes the human gene encoding it.
See Aripiprazole and Alpha-1A adrenergic receptor
Alpha-1B adrenergic receptor
The alpha-1B adrenergic receptor (α1B-adrenoreceptor), also known as ADRA1B, is an alpha-1 adrenergic receptor, and also denotes the human gene encoding it.
See Aripiprazole and Alpha-1B adrenergic receptor
Alpha-2A adrenergic receptor
The alpha-2A adrenergic receptor (α2A adrenoceptor), also known as ADRA2A, is an α2 adrenergic receptor, and also denotes the human gene encoding it.
See Aripiprazole and Alpha-2A adrenergic receptor
Alpha-2B adrenergic receptor
The alpha-2B adrenergic receptor (α2B adrenoceptor), is a G-protein coupled receptor.
See Aripiprazole and Alpha-2B adrenergic receptor
Alpha-2C adrenergic receptor
The alpha-2C adrenergic receptor (α2C adrenoceptor), also known as ADRA2C, is an alpha-2 adrenergic receptor, and also denotes the human gene encoding it.
See Aripiprazole and Alpha-2C adrenergic receptor
Amphetamine
Amphetamine (contracted from alpha-methylphenethylamine) is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity.
See Aripiprazole and Amphetamine
Amphetamine dependence
Amphetamine dependence refers to a state of psychological dependence on a drug in the amphetamine class.
See Aripiprazole and Amphetamine dependence
Anaphylaxis
Anaphylaxis (Greek: ana- ‘against’ + phylaxis ‘guarding’) is a serious, potentially fatal allergic reaction and medical emergency that is rapid in onset and requires immediate medical attention regardless of the use of emergency medication on site.
See Aripiprazole and Anaphylaxis
Anorexia (symptom)
Anorexia is a medical term for a loss of appetite.
See Aripiprazole and Anorexia (symptom)
Antipsychotic
Antipsychotics, previously known as neuroleptics and major tranquilizers, are a class of psychotropic medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia but also in a range of other psychotic disorders.
See Aripiprazole and Antipsychotic
Aripiprazole lauroxil
Aripiprazole lauroxil, sold under the brand name Aristada, is a long-acting injectable atypical antipsychotic that was developed by Alkermes.
See Aripiprazole and Aripiprazole lauroxil
Asenapine
Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder as well as the medium to long-term management of bipolar disorder. Aripiprazole and Asenapine are alpha-2 blockers and atypical antipsychotics.
See Aripiprazole and Asenapine
Attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and otherwise age-inappropriate.
See Aripiprazole and Attention deficit hyperactivity disorder
Atypical antipsychotic
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric conditions. Aripiprazole and atypical antipsychotic are atypical antipsychotics.
See Aripiprazole and Atypical antipsychotic
Australia
Australia, officially the Commonwealth of Australia, is a country comprising the mainland of the Australian continent, the island of Tasmania, and numerous smaller islands.
See Aripiprazole and Australia
Autism
Autism, also called autism spectrum disorder (ASD) or autism spectrum condition (ASC), is a neurodevelopmental disorder characterised by symptoms of deficient reciprocal social communication and the presence of restricted, repetitive and inflexible patterns of behavior that are impairing in multiple contexts and excessive or atypical to be developmentally and socioculturally inappropriate.
Barr Pharmaceuticals
Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.
See Aripiprazole and Barr Pharmaceuticals
Beta-1 adrenergic receptor
The beta-1 adrenergic receptor (β1 adrenoceptor), also known as ADRB1, can refer to either the protein-encoding gene (gene ADRB1) or one of the four adrenergic receptors.
See Aripiprazole and Beta-1 adrenergic receptor
Beta-2 adrenergic receptor
The beta-2 adrenergic receptor (β2 adrenoreceptor), also known as ADRB2, is a cell membrane-spanning beta-adrenergic receptor that binds epinephrine (adrenaline), a hormone and neurotransmitter whose signaling, via adenylate cyclase stimulation through trimeric Gs proteins, increases cAMP, and, via downstream L-type calcium channel interaction, mediates physiologic responses such as smooth muscle relaxation and bronchodilation.
See Aripiprazole and Beta-2 adrenergic receptor
Bioavailability
In pharmacology, bioavailability is a subcategory of absorption and is the fraction (%) of an administered drug that reaches the systemic circulation.
See Aripiprazole and Bioavailability
Bipolar disorder
Bipolar disorder, previously known as manic depression, is a mental disorder characterized by periods of depression and periods of abnormally elevated mood that each last from days to weeks.
See Aripiprazole and Bipolar disorder
Bloomberg L.P.
Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.
See Aripiprazole and Bloomberg L.P.
Boxed warning
In the United States, a boxed warning (sometimes "black box warning", colloquially) is a type of warning that appears near the beginning of the package insert for certain prescription drugs, so called because the U.S. Food and Drug Administration specifies that it is formatted with a 'box' or border around the text to emphasize it is of utmost importance.
See Aripiprazole and Boxed warning
Breastfeeding
Breastfeeding, variously known as chestfeeding or nursing, is the process where breast milk is fed to a child.
See Aripiprazole and Breastfeeding
Bristol Myers Squibb
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company.
See Aripiprazole and Bristol Myers Squibb
British National Formulary
The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS).
See Aripiprazole and British National Formulary
Carbamazepine
Carbamazepine, sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain. Aripiprazole and Carbamazepine are mood stabilizers.
See Aripiprazole and Carbamazepine
Cariprazine
Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, which is used in the treatment of schizophrenia, bipolar mania, bipolar depression, and major depressive disorder. Aripiprazole and Cariprazine are atypical antipsychotics, mood stabilizers and serotonin-dopamine activity modulators.
See Aripiprazole and Cariprazine
Case report
In medicine, a case report is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient.
See Aripiprazole and Case report
Caudate nucleus
The caudate nucleus is one of the structures that make up the corpus striatum, which is a component of the basal ganglia in the human brain.
See Aripiprazole and Caudate nucleus
Chemical synapse
Chemical synapses are biological junctions through which neurons' signals can be sent to each other and to non-neuronal cells such as those in muscles or glands.
See Aripiprazole and Chemical synapse
Chlorpromazine
Chlorpromazine (CPZ), marketed under the brand names Thorazine and Largactil among others, is an antipsychotic medication. Aripiprazole and Chlorpromazine are alpha-1 blockers and alpha-2 blockers.
See Aripiprazole and Chlorpromazine
Citalopram
Citalopram, sold under the brand name Celexa among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
See Aripiprazole and Citalopram
Clinical trial
Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison.
See Aripiprazole and Clinical trial
Clozapine
Clozapine is a psychiatric medication and was the first atypical antipsychotic (also called second-generation antipsychotic) to be discovered. Aripiprazole and Clozapine are alpha-1 blockers, alpha-2 blockers, atypical antipsychotics and mood stabilizers.
See Aripiprazole and Clozapine
Cochrane (organisation)
Cochrane is a British international charitable organisation formed to synthesize medical research findings to facilitate evidence-based choices about health interventions involving health professionals, patients and policy makers.
See Aripiprazole and Cochrane (organisation)
Crystal polymorphism
In crystallography, polymorphism is the phenomenon where a compound or element can crystallize into more than one crystal structure.
See Aripiprazole and Crystal polymorphism
CYP2D6
Cytochrome P450 2D6 (CYP2D6) is an enzyme that in humans is encoded by the CYP2D6 gene.
CYP3A4
Cytochrome P450 3A4 (abbreviated CYP3A4) is an important enzyme in the body, mainly found in the liver and in the intestine, which in humans is encoded by CYP3A4 gene.
Dementia
Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities.
Depression (mood)
Depression is a mental state of low mood and aversion to activity.
See Aripiprazole and Depression (mood)
Diário Oficial da União
The Diário Oficial da União (literally Official Diary of the Union), abbreviated DOU, is the official journal of the federal government of Brazil.
See Aripiprazole and Diário Oficial da União
Digital pill
A digital pill (also known as a smart pill, or ingestible sensor) is a pharmaceutical dosage form that contains an ingestible sensor inside of a pill.
See Aripiprazole and Digital pill
Dopamine receptor D1
Dopamine receptor D1, also known as DRD1.
See Aripiprazole and Dopamine receptor D1
Dopamine receptor D2
Dopamine receptor D2, also known as D2R, is a protein that, in humans, is encoded by the DRD2 gene.
See Aripiprazole and Dopamine receptor D2
Dopamine receptor D3
Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.
See Aripiprazole and Dopamine receptor D3
Dopamine receptor D4
The dopamine receptor D4 is a dopamine D2-like G protein-coupled receptor encoded by the gene on chromosome 11 at 11p15.5.
See Aripiprazole and Dopamine receptor D4
Dopamine receptor D5
Dopamine receptor D5, also known as D1BR, is a protein that in humans is encoded by the DRD5 gene.
See Aripiprazole and Dopamine receptor D5
Dopaminergic
Dopaminergic means "related to dopamine" (literally, "working on dopamine"), dopamine being a common neurotransmitter.
See Aripiprazole and Dopaminergic
Drug development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
See Aripiprazole and Drug development
Drug discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
See Aripiprazole and Drug discovery
Drug Price Competition and Patent Term Restoration Act
The Drug Price Competition and Patent Term Restoration Act (Public Law 98-417), informally known as the Hatch-Waxman Act, is a 1984 United States federal law that established the modern system of generic drug regulation in the United States.
See Aripiprazole and Drug Price Competition and Patent Term Restoration Act
Escitalopram
Escitalopram, sold under the brand names Lexapro and Cipralex, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
See Aripiprazole and Escitalopram
Etoperidone
Etoperidone, associated with several brand names, is an atypical antidepressant which was developed in the 1970s and either is no longer marketed or was never marketed. Aripiprazole and Etoperidone are 5-HT2A antagonists, alpha-1 blockers and alpha-2 blockers.
See Aripiprazole and Etoperidone
European Medicines Agency
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products.
See Aripiprazole and European Medicines Agency
Extrapyramidal symptoms
Extrapyramidal symptoms (EPS) are symptoms that are archetypically associated with the extrapyramidal system of the brain's cerebral cortex.
See Aripiprazole and Extrapyramidal symptoms
Feces
Feces (or faeces;: faex) are the solid or semi-solid remains of food that was not digested in the small intestine, and has been broken down by bacteria in the large intestine.
Fluoxetine
Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
See Aripiprazole and Fluoxetine
Fluvoxamine
Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Aripiprazole and Fluvoxamine are Ethers.
See Aripiprazole and Fluvoxamine
Food and Drug Administration
The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services.
See Aripiprazole and Food and Drug Administration
Functional selectivity
Functional selectivity (or “agonist trafficking”, “biased agonism”, “biased signaling”, "ligand bias" and “differential engagement”) is the ligand-dependent selectivity for certain signal transduction pathways relative to a reference ligand (often the endogenous hormone or peptide) at the same receptor.
See Aripiprazole and Functional selectivity
G protein
G proteins, also known as guanine nucleotide-binding proteins, are a family of proteins that act as molecular switches inside cells, and are involved in transmitting signals from a variety of stimuli outside a cell to its interior.
See Aripiprazole and G protein
GABAA-rho receptor
The GABAA-rho receptor (previously known as the GABAC receptor) is a subclass of GABAA receptors composed entirely of rho (ρ) subunits.
See Aripiprazole and GABAA-rho receptor
Generic drug
A generic drug (or simply generic) is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents.
See Aripiprazole and Generic drug
Haloperidol
Haloperidol, sold under the brand name Haldol among others, is a typical antipsychotic medication.
See Aripiprazole and Haloperidol
Headache
Headache, also known as cephalalgia, is the symptom of pain in the face, head, or neck.
Histamine H1 receptor
The H1 receptor is a histamine receptor belonging to the family of rhodopsin-like G-protein-coupled receptors.
See Aripiprazole and Histamine H1 receptor
Histamine H2 receptor
H2 receptors are a type of histamine receptor found in many parts of the anatomy of humans and other animals.
See Aripiprazole and Histamine H2 receptor
Histamine H3 receptor
Histamine H3 receptors are expressed in the central nervous system and to a lesser extent the peripheral nervous system, where they act as autoreceptors in presynaptic histaminergic neurons and control histamine turnover by feedback inhibition of histamine synthesis and release.
See Aripiprazole and Histamine H3 receptor
Histamine H4 receptor
The histamine H4 receptor, like the other three histamine receptors, is a member of the G protein-coupled receptor superfamily that in humans is encoded by the HRH4 gene.
See Aripiprazole and Histamine H4 receptor
Histamine receptor
The histamine receptors are a class of G protein–coupled receptors which bind histamine as their primary endogenous ligand.
See Aripiprazole and Histamine receptor
In vitro
In vitro (meaning in glass, or in the glass) studies are performed with microorganisms, cells, or biological molecules outside their normal biological context.
Intramuscular injection
Intramuscular injection, often abbreviated IM, is the injection of a substance into a muscle.
See Aripiprazole and Intramuscular injection
Intrinsic activity
Intrinsic activity (IA) and efficacy refer to the relative ability of a drug-receptor complex to produce a maximum functional response.
See Aripiprazole and Intrinsic activity
Inverse agonist
In pharmacology, an inverse agonist is a drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist.
See Aripiprazole and Inverse agonist
Journal of Psychopharmacology
The Journal of Psychopharmacology is a monthly peer-reviewed scientific journal published by SAGE Publications on behalf of the British Association for Psychopharmacology.
See Aripiprazole and Journal of Psychopharmacology
Kidney
In humans, the kidneys are two reddish-brown bean-shaped blood-filtering organs that are a multilobar, multipapillary form of mammalian kidneys, usually without signs of external lobulation.
Ligand (biochemistry)
In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose.
See Aripiprazole and Ligand (biochemistry)
Liver
The liver is a major metabolic organ exclusively found in vertebrate animals, which performs many essential biological functions such as detoxification of the organism, and the synthesis of proteins and various other biochemicals necessary for digestion and growth.
Lundbeck
H.
Major depressive disorder
Major depressive disorder (MDD), also known as clinical depression, is a mental disorder characterized by at least two weeks of pervasive low mood, low self-esteem, and loss of interest or pleasure in normally enjoyable activities.
See Aripiprazole and Major depressive disorder
Mania
Mania, also known as manic syndrome, is a mental and behavioral disorder defined as a state of abnormally elevated arousal, affect, and energy level, or "a state of heightened overall activation with enhanced affective expression together with lability of affect." During a manic episode, an individual will experience rapidly changing emotions and moods, highly influenced by surrounding stimuli.
Mechanism of action
In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect.
See Aripiprazole and Mechanism of action
Medscape
Medscape is a website providing access to medical information for clinicians and medical scientists; the organization also provides continuing education for physicians and other health professionals.
Mesocortical pathway
The mesocortical pathway is a dopaminergic pathway that connects the ventral tegmentum to the prefrontal cortex.
See Aripiprazole and Mesocortical pathway
Mesolimbic pathway
The mesolimbic pathway, sometimes referred to as the reward pathway, is a dopaminergic pathway in the brain.
See Aripiprazole and Mesolimbic pathway
Meta-analysis
Meta-analysis is the statistical combination of the results of multiple studies addressing a similar research question.
See Aripiprazole and Meta-analysis
Mixed affective state
A mixed affective state, formerly known as a mixed-manic or mixed episode, has been defined as a state wherein features and symptoms unique to both depression and (hypo)mania, including episodes of anguish, despair, self doubt, rage, excessive impulsivity and suicidal ideation, sensory overload, racing thoughts, heightened irritability, decreased "need" for sleep and other symptoms of depressive and manic states occur either simultaneously or in very short succession.
See Aripiprazole and Mixed affective state
Mood stabilizer
A mood stabilizer is a psychiatric medication used to treat mood disorders characterized by intense and sustained mood shifts, such as bipolar disorder and the bipolar type of schizoaffective disorder. Aripiprazole and mood stabilizer are mood stabilizers.
See Aripiprazole and Mood stabilizer
Movement disorder
Movement disorders are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements, unrelated to weakness or spasticity.
See Aripiprazole and Movement disorder
Muscarinic acetylcholine receptor
Muscarinic acetylcholine receptors, or mAChRs, are acetylcholine receptors that form G protein-coupled receptor complexes in the cell membranes of certain neurons and other cells.
See Aripiprazole and Muscarinic acetylcholine receptor
Muscarinic acetylcholine receptor M1
The muscarinic acetylcholine receptor M1, also known as the cholinergic receptor, muscarinic 1, is a muscarinic receptor that in humans is encoded by the CHRM1 gene.
See Aripiprazole and Muscarinic acetylcholine receptor M1
Muscarinic acetylcholine receptor M2
The muscarinic acetylcholine receptor M2, also known as the cholinergic receptor, muscarinic 2, is a muscarinic acetylcholine receptor that in humans is encoded by the CHRM2 gene.
See Aripiprazole and Muscarinic acetylcholine receptor M2
Muscarinic acetylcholine receptor M3
The muscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or the muscarinic 3, is a muscarinic acetylcholine receptor encoded by the human gene CHRM3.
See Aripiprazole and Muscarinic acetylcholine receptor M3
Muscarinic acetylcholine receptor M4
The muscarinic acetylcholine receptor M4, also known as the cholinergic receptor, muscarinic 4 (CHRM4), is a protein that, in humans, is encoded by the CHRM4 gene.
See Aripiprazole and Muscarinic acetylcholine receptor M4
Muscarinic acetylcholine receptor M5
The human muscarinic acetylcholine receptor M5, encoded by the gene, is a member of the G protein-coupled receptor superfamily of integral membrane proteins.
See Aripiprazole and Muscarinic acetylcholine receptor M5
National Center for Biotechnology Information
The National Center for Biotechnology Information (NCBI) is part of the United States National Library of Medicine (NLM), a branch of the National Institutes of Health (NIH).
See Aripiprazole and National Center for Biotechnology Information
National Institute for Health and Care Excellence
The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body, in England, of the Department of Health and Social Care, that publishes guidelines in four areas.
See Aripiprazole and National Institute for Health and Care Excellence
Nefazodone
Nefazodone, sold formerly under the brand names Serzone, Dutonin, and Nefadar among others, is an atypical antidepressant medication which is used in the treatment of depression and for other uses. Aripiprazole and Nefazodone are 5-HT2A antagonists, alpha-1 blockers and alpha-2 blockers.
See Aripiprazole and Nefazodone
Neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening reaction that can occur in response to antipsychotic (neuroleptic) medications.
See Aripiprazole and Neuroleptic malignant syndrome
NMDA receptor
The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and predominantly Ca2+ ion channel found in neurons.
See Aripiprazole and NMDA receptor
Obesity
Obesity is a medical condition, sometimes considered a disease, in which excess body fat has accumulated to such an extent that it can potentially have negative effects on health.
Obsessive–compulsive disorder
Obsessive–compulsive disorder (OCD) is a mental and behavioral disorder in which an individual has intrusive thoughts (an obsession) and feels the need to perform certain routines (compulsions) repeatedly to relieve the distress caused by the obsession, to the extent where it impairs general function.
See Aripiprazole and Obsessive–compulsive disorder
Off-label use
Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.
See Aripiprazole and Off-label use
Olanzapine
Olanzapine, sold under the brand name Zyprexa among others, is an atypical antipsychotic primarily used to treat schizophrenia and bipolar disorder. Aripiprazole and Olanzapine are 5-HT2A antagonists, 5-HT2B antagonists, 5-HT7 antagonists, alpha-1 blockers, alpha-2 blockers, atypical antipsychotics, d2 antagonists, d3 antagonists and mood stabilizers.
See Aripiprazole and Olanzapine
Open-label trial
An open-label trial, or open trial, is a type of clinical trial in which information is not withheld from trial participants.
See Aripiprazole and Open-label trial
Oral administration
| name.
See Aripiprazole and Oral administration
Otsuka Pharmaceutical
(), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan.
See Aripiprazole and Otsuka Pharmaceutical
Paroxetine
Paroxetine, sold under the brand names Paxil and Seroxat among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used to treat major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, post-traumatic stress disorder, generalized anxiety disorder, and premenstrual dysphoric disorder.
See Aripiprazole and Paroxetine
Partial agonist
In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist.
See Aripiprazole and Partial agonist
Pervasive developmental disorder
The diagnostic category pervasive developmental disorders (PDD), as opposed to specific developmental disorders (SDD), was a group of disorders characterized by delays in the development of multiple basic functions including socialization and communication.
See Aripiprazole and Pervasive developmental disorder
Pharmacodynamics
Pharmacodynamics (PD) is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs).
See Aripiprazole and Pharmacodynamics
Positron emission tomography
Positron emission tomography (PET) is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption.
See Aripiprazole and Positron emission tomography
Pregnancy
Pregnancy is the time during which one or more offspring develops (gestates) inside a woman's uterus (womb).
See Aripiprazole and Pregnancy
Prodrug
A prodrug is a pharmacologically inactive medication or compound that, after intake, is metabolized (i.e., converted within the body) into a pharmacologically active drug.
Prolactin
Prolactin (PRL), also known as lactotropin and mammotropin, is a protein best known for its role in enabling mammals to produce milk.
See Aripiprazole and Prolactin
Psychomotor agitation
Psychomotor agitation is a symptom in various disorders and health conditions.
See Aripiprazole and Psychomotor agitation
Putamen
The putamen (from Latin, meaning "nutshell") is a round structure located at the base of the forebrain (telencephalon).
QT interval
The QT interval is a measurement made on an electrocardiogram used to assess some of the electrical properties of the heart.
See Aripiprazole and QT interval
Quality of life
Quality of life (QOL) is defined by the World Health Organization as "an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns".
See Aripiprazole and Quality of life
Quetiapine
Quetiapine, sold under the brand name Seroquel among others, is an atypical antipsychotic medication used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder. Aripiprazole and Quetiapine are 5-HT2A antagonists, alpha-1 blockers, alpha-2 blockers, atypical antipsychotics, Ethers and mood stabilizers.
See Aripiprazole and Quetiapine
Randomized controlled trial
A randomized controlled trial (or randomized control trial; RCT) is a form of scientific experiment used to control factors not under direct experimental control.
See Aripiprazole and Randomized controlled trial
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
See Aripiprazole and Receptor antagonist
Risperidone
Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Aripiprazole and Risperidone are alpha-1 blockers, alpha-2 blockers, atypical antipsychotics, mood stabilizers and treatment of autism.
See Aripiprazole and Risperidone
Schizophrenia
Schizophrenia is a mental disorder characterized by reoccurring episodes of psychosis that are correlated with a general misperception of reality.
See Aripiprazole and Schizophrenia
Sedation
Sedation is the reduction of irritability or agitation by administration of sedative drugs, generally to facilitate a medical procedure or diagnostic procedure.
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder, anxiety disorders, and other psychological conditions.
See Aripiprazole and Selective serotonin reuptake inhibitor
Serotonin
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.
See Aripiprazole and Serotonin
Serotonin transporter
The serotonin transporter (SERT or 5-HTT) also known as the sodium-dependent serotonin transporter and solute carrier family 6 member 4 is a protein that in humans is encoded by the SLC6A4 gene.
See Aripiprazole and Serotonin transporter
Sertraline
Sertraline, sold under the brand name Zoloft among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
See Aripiprazole and Sertraline
Stereotypy
A stereotypy is a repetitive or ritualistic movement, posture, or utterance.
See Aripiprazole and Stereotypy
Striatum
The striatum (striata) or corpus striatum is a cluster of interconnected nuclei that make up the largest structure of the subcortical basal ganglia.
Substance use disorder
Substance use disorder (SUD) is the persistent use of drugs despite the substantial harm and adverse consequences to one's own self and others, as a result of their use.
See Aripiprazole and Substance use disorder
Suicide
Suicide is the act of intentionally causing one's own death.
Supplementary protection certificate
In the European Economic Area (European Union member countries, Iceland, Liechtenstein and Norway), a supplementary protection certificate (SPC) is a sui generis intellectual property (IP) right that extends the duration of certain rights associated with a patent.
See Aripiprazole and Supplementary protection certificate
Systematic review
A systematic review is a scholarly synthesis of the evidence on a clearly presented topic using critical methods to identify, define and assess research on the topic.
See Aripiprazole and Systematic review
Tardive dyskinesia
Tardive dyskinesia (TD) is a disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips.
See Aripiprazole and Tardive dyskinesia
Teva Pharmaceuticals
Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company.
See Aripiprazole and Teva Pharmaceuticals
The Lancet
The Lancet is a weekly peer-reviewed general medical journal and one of the oldest of its kind.
See Aripiprazole and The Lancet
Therapeutic Goods Administration
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government.
See Aripiprazole and Therapeutic Goods Administration
Tic disorder
Tic disorders are defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM) based on type (motor or phonic) and duration of tics (sudden, rapid, nonrhythmic movements).
See Aripiprazole and Tic disorder
Tourette syndrome
Tourette syndrome or Tourette's syndrome (abbreviated as TS or Tourette's) is a common neurodevelopmental disorder that begins in childhood or adolescence.
See Aripiprazole and Tourette syndrome
Trazodone
Trazodone, sold under many brand names, is an antidepressant medication. Aripiprazole and Trazodone are 5-HT2A antagonists and alpha-1 blockers.
See Aripiprazole and Trazodone
Treatment and control groups
In the design of experiments, hypotheses are applied to experimental units in a treatment group.
See Aripiprazole and Treatment and control groups
United Kingdom
The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (UK) or Britain, is a country in Northwestern Europe, off the coast of the continental mainland.
See Aripiprazole and United Kingdom
United States District Court for the District of New Jersey
The United States District Court for the District of New Jersey (in case citations, D.N.J.) is a federal court in the Third Circuit (except for patent claims and claims against the U.S. government under the Tucker Act, which are appealed to the Federal Circuit).
See Aripiprazole and United States District Court for the District of New Jersey
Valproate
Valproate (valproic acid, VPA, sodium valproate, and valproate semisodium forms) are medications primarily used to treat epilepsy and bipolar disorder and prevent migraine headaches. Aripiprazole and valproate are mood stabilizers.
See Aripiprazole and Valproate
Weight gain
Weight gain is an increase in body weight.
See Aripiprazole and Weight gain
WHO Model List of Essential Medicines
The WHO Model List of Essential Medicines (aka Essential Medicines List or EML), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe to meet the most important needs in a health system.
See Aripiprazole and WHO Model List of Essential Medicines
Ziprasidone
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. Aripiprazole and Ziprasidone are atypical antipsychotics and mood stabilizers.
See Aripiprazole and Ziprasidone
2,3-Dichlorophenylpiperazine
2,3-Dichlorophenylpiperazine (2,3-DCPP or DCPP) is a chemical compound from the phenylpiperazine family.
See Aripiprazole and 2,3-Dichlorophenylpiperazine
5-HT receptor
5-HT receptors, 5-hydroxytryptamine receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems.
See Aripiprazole and 5-HT receptor
5-HT1A receptor
The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptors, or 5-HT receptors, that binds serotonin, also known as 5-HT, a neurotransmitter.
See Aripiprazole and 5-HT1A receptor
5-HT1B receptor
5-hydroxytryptamine receptor 1B also known as the 5-HT1B receptor is a protein that in humans is encoded by the HTR1B gene.
See Aripiprazole and 5-HT1B receptor
5-HT1D receptor
5-hydroxytryptamine (serotonin) receptor 1D, also known as HTR1D, is a 5-HT receptor, but also denotes the human gene encoding it.
See Aripiprazole and 5-HT1D receptor
5-HT1E receptor
5-hydroxytryptamine (serotonin) 1E receptor (5-HT1E) is a highly expressed human G-protein coupled receptor that belongs to the 5-HT1 receptor family (Gi-coupled serotonin receptor).
See Aripiprazole and 5-HT1E receptor
5-HT2A receptor
The 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR).
See Aripiprazole and 5-HT2A receptor
5-HT2B receptor
5-Hydroxytryptamine receptor 2B (5-HT2B) also known as serotonin receptor 2B is a protein that in humans is encoded by the HTR2B gene.
See Aripiprazole and 5-HT2B receptor
5-HT2C receptor
The 5-HT2C receptor is a subtype of the 5-HT2 receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
See Aripiprazole and 5-HT2C receptor
5-HT3 receptor
The 5-HT3 receptor belongs to the Cys-loop superfamily of ligand-gated ion channels (LGICs) and therefore differs structurally and functionally from all other 5-HT receptors (5-hydroxytryptamine, or serotonin receptors) which are G protein-coupled receptors.
See Aripiprazole and 5-HT3 receptor
5-HT5A receptor
5-Hydroxytryptamine (serotonin) receptor 5A, also known as HTR5A, is a protein that in humans is encoded by the HTR5A gene.
See Aripiprazole and 5-HT5A receptor
5-HT6 receptor
The 5HT6 receptor is a subtype of 5HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5HT).
See Aripiprazole and 5-HT6 receptor
5-HT7 receptor
The 5-HT7 receptor is a member of the GPCR superfamily of cell surface receptors and is activated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
See Aripiprazole and 5-HT7 receptor
See also
5-HT2B antagonists
- Amesergide
- Amisulpride
- Apomorphine
- Aripiprazole
- Brexpiprazole
- Brilaroxazine
- Bromocriptine
- LY-272,015
- Meta-Chlorophenylpiperazine
- Olanzapine
- PRX-08066
- Pipamperone
- Propranolol
- RS-127445
- Rauwolscine
- SB-204741
- SB-215505
- TIK-301
- Tenilapine
- Viloxazine
5-HT2C agonists
- 25I-NBOMe
- 2CBCB-NBOMe
- 3,4-Methylenedioxyamphetamine
- 5-HT2C receptor agonist
- Aripiprazole
- Fenfluramine
- Flumexadol
- Lorcaserin
- MDMA
- Meta-Chlorophenylpiperazine
- Oxaflozane
- TCB-2
- Viloxazine
- WAY-163909
5-HT7 antagonists
- Amesergide
- Amisulpride
- Aripiprazole
- Brexpiprazole
- Brilaroxazine
- Chlorprothixene
- DR-4485
- Ketanserin
- Lurasidone
- Olanzapine
- Pimozide
- SB-258719
- SB-269970
- Tiotixene
- Vortioxetine
Atypical antipsychotics
- Amisulpride
- Amoxapine
- Aripiprazole
- Aripiprazole/sertraline
- Asenapine
- Atypical antipsychotic
- Bifeprunox
- Blonanserin
- Brexpiprazole
- Brilaroxazine
- Bromerguride
- Cariprazine
- Carpipramine
- Clocapramine
- Clotiapine
- Clozapine
- Cycloserine/lurasidone
- DHA-clozapine
- Gevotroline
- Iloperidone
- Lumateperone
- Lurasidone
- Melperone
- Mosapramine
- Nemonapride
- Olanzapine
- Olanzapine/fluoxetine
- Olanzapine/samidorphan
- Paliperidone
- Perospirone
- Pimavanserin
- Piquindone
- Quetiapine
- Remoxipride
- Risperidone
- Sertindole
- Sulpiride
- Sultopride
- Tenilapine
- Tiapride
- Zicronapine
- Ziprasidone
- Zotepine
D2 antagonists
- 3-PPP
- Aceprometazine
- Amisulpride
- Aripiprazole
- BL-1020
- Blonanserin
- Buspirone
- Buspirone/testosterone
- Chlorprothixene
- Desmethoxyfallypride
- Deudomperidone
- Doxepin
- Eticlopride
- Fallypride
- Flunarizine
- Hydroxyzine
- Imipramine
- Itopride
- Ketanserin
- L-741,626
- Metoclopramide
- Metopimazine
- Ocaperidone
- Olanzapine
- Opipramol
- Panamesine
- Pimozide
- Pipamperone
- Pridopidine
- Raclopride
- Sarizotan
- Spiperone
- Stepholidine
- Terguride
- Tetrahydropalmatine
- Tiotixene
- Trazpiroben
- Trimethobenzamide
D2-receptor agonists
- Apomorphine
- Aripiprazole
- Brexpiprazole
- Brilaroxazine
- Cabergoline
- Deoxyepinephrine
- Dihydrexidine
- Dihydroergocryptine
- Dinoxyline
- Dopexamine
- Ibopamine
- Ketamine
- Lisuride
- Modafinil
- Pardoprunox
- Pergolide
- Phencyclidine
- Quinagolide
- Rotigotine
- SKF-83,959
- Salvinorin A
- Talipexole
- Terguride
D3 antagonists
- Amisulpride
- Aripiprazole
- Blonanserin
- Buspirone
- Chlorprothixene
- Deudomperidone
- Metopimazine
- Olanzapine
- Panamesine
- Pimozide
- Pipamperone
- SB-277,011-A
- Tiotixene
- Trazpiroben
D3 receptor agonists
- Apomorphine
- Aripiprazole
- Brexpiprazole
- Cabergoline
- Dihydroergocryptine
- Dinoxyline
- Lisuride
- Pardoprunox
- Pergolide
- Rotigotine
- Terguride
Mood stabilizers
- Aripiprazole
- Carbamazepine
- Cariprazine
- Clozapine
- Histone deacetylase inhibitor
- Lamotrigine
- Licarbazepine
- List of adverse effects of valproate semisodium
- List of antidepressants
- List of investigational antidepressants
- Lithium (medication)
- Lithium bromide
- Lithium carbonate
- Lithium chloride
- Lithium citrate
- Lithium orotate
- Lithium sulfate
- Lurasidone
- Mood stabilizer
- Olanzapine
- Olanzapine/fluoxetine
- Oxcarbazepine
- Paliperidone
- Quetiapine
- Risperidone
- Tamoxifen
- Valnoctamide
- Valproate
- Valproate pivoxil
- Valpromide
- Ziprasidone
Otsuka Pharmaceutical
- Aripiprazole
- Astex Pharmaceuticals
- Brexpiprazole
- CalorieMate
- Cilostazol
- Crystal Geyser Water Company
- Daiya
- Dasatinib
- Decitabine
- Decitabine/cedazuridine
- Dextromethorphan/quinidine
- Fibe Mini
- Global Health Innovative Technology Fund
- Oronamin C
- Otsuka Pharmaceutical
- Pharmavite
- Pocari Sweat
- Pocari Sweat Open
- Rejoyn
- Ridge Vineyards
- Taiho Pharmaceutical
- Tokushima Vortis
- Tolvaptan
- Ōtsuka Museum of Art
Serotonin-dopamine activity modulators
- Aripiprazole
- Brexpiprazole
- Cariprazine
- Lumateperone
- Olanzapine/samidorphan
Tetrahydroquinolines
- 2-Methyltetrahydroquinoline
- Aripiprazole
- Baxdrostat
- CIM-0216
- Flumequine
- Julolidine
- Mavorixafor
- Mosliciguat
- Oxamniquine
- Quinfamide
- THQ-PINACA
- Tetrahydroquinoline
- Zoliflodacin
Treatment of autism
- Aripiprazole
- Association for Science in Autism Treatment
- Autism assistance dog
- Autism therapies
- Circle of Friends (disabled care)
- Developmental social-pragmatic model
- Discrete trial training
- Early Start Denver Model
- Floortime
- Hug machine
- Intensive interaction
- Meristem (school)
- Picture Exchange Communication System
- Pivotal response treatment
- Relationship Development Intervention
- Risperidone
- Secretin
- Snoezelen
- Social Stories
- Social narrative
- Treatment and Education of Autistic and Related Communication Handicapped Children
- Video modeling
- Visual schedules
References
Also known as ATC code N05AX12, ATCvet code QN05AX12, Abilify, Abilify Asimtufii, Abilify Maintena, Abilify MyCite, Abilitat, Abizol, Arip MT, Aripiprazole cavoxil, Aripiprazole monohydrate, Aripiprex, Aripiprozole, Ariprazole, Biopiprazole, C23H27Cl2N3O2, OPC-14597.